Health Professional Radio - Podcast
1,640 episodes - English - Latest episode: 3 months ago - ★★★★ - 3 ratingsHealth Professional radio gives you access to interesting and entertaining interviews, news updates, professional profiles, research updates on a broad range of topics related to health.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Cantex Pharmaceuticals - Continued Development of Cancer Therapies and More
January 17, 2024 14:03 - 8 minutes - 8.23 MBReturning guest, Dr. Steve Marcus, CEO of Cantex Pharmaceuticals, a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions for which new treatments are urgently needed discusses Azeliragon and the launch of investigator-led clinical studies focusing on a combination with radiosurgery in patients with brain metastases, front-line treatment for glioblastoma, metastatic pancreatic cancer and treatment of pati...
New type of AI-Powered Data Fills Gaps Left By Clinical Trials
January 17, 2024 14:02 - 9 minutes - 9.2 MBDr. Michael R. Jaff, Vice President and Chief Medical Officer, Peripheral Interventions at Boston Scientific and Dr. Peter Monteleone, MD, FACC, FSCAI an interventional cardiologist and vascular medicine physician at Ascension Texas Cardiovascular in Austin, Texas and principal investigator of the REAL-PE study talk about the study results and the potential for real-world data to improve patient care in pulmonary embolism treatment and beyond. #REALPEStudy #EKOS #Truveta Michael R. Jaff, D...
Immunocore - FDA Approved Treatment for Metastatic Uveal Melanoma
January 17, 2024 14:01 - 7 minutes - 10.4 MBDavid Berman, Head of Research and Development at Immunocore discusses the 3-year overall survival data from the KIMMTRAK Phase 3 trial that was presented at the European Society of Medical Oncology (ESMO) 2023 for their FDA approved treatment for uveal melanoma, a very deadly type of cancer in the eye. It was the first-ever approved treatment in the space. #Immunocore Dr. David Berman is Head of Research and Development. Over his career, David has worked on multiple immuno-oncology (IO...
Spirovant Sciences - Potential of Gene Therapy in Targeting the Drivers of Cystic Fibrosis
January 17, 2024 14:00 - 12 minutes - 17.7 MBJoan Lau, Ph.D., MBA, CEO of Spirovant Sciences discusses cystic fibrosis (CF) and how the standard of care right now addresses but does not correct the underlying cause of the disease. She talks about what needs to be done, and how her organization is working to revolutionize treatment for people living with CF by directly targeting and correcting the underlying cause of the disease. #SpirovantSciences Joan Lau is Chief Executive Officer of Philadelphia-based biotech Spirovant Sciences. S...
Lucid Diagnostics - EsoGuard ® Esophageal DNA Test
January 17, 2024 13:59 - 9 minutes - 8.43 MBDr. Lishan Aklog, MD, Chairman and CEO of Lucid Diagnostics, a commercial-stage cancer prevention diagnostics company, discusses the company’s EsoGuard ® Esophageal DNA Test and EsoCheck ® Esophageal Cell Collection Device, the first and only commercially available tools designed with the goal of preventing cancer and cancer deaths through widespread, early detection of esophageal precancer, targeting the millions of patients with gastroesophageal reflux disease (GERD), also known as chroni...
Ultra-Rare Inherited Form of High Cholesterol is Dangerously Underdiagnosed and Undertreated
January 17, 2024 13:58 - 9 minutes - 9.25 MBDr. Mary McGowan, MD, Chief Medical Officer at the Family Heart Foundation, discusses a recent study that revealed concerning findings showing the diagnosis and treatment of a rare genetic disorder, homozygous familial hypercholesterolemia (HoFH), is dangerously underdiagnosed and undertreated. Results published in the Journal of the American Heart Association (JAHA) by the Family Heart Foundation found that diagnosis of HoFH, a condition which can lead to severely elevated low-density lipop...
CIONIC - Bionic Clothing Medical Device for the Mobility Impaired
December 14, 2023 06:29 - 9 minutes - 12.7 MBJeremiah Robison, Founder and CEO of CIONIC discusses the company's success with the FDA-Cleared Cionic Neural Sleeve, the first bionic clothing to combine sensing, analysis, and augmentation to help individuals with neurological conditions like multiple sclerosis, stroke, and cerebral palsy live more freely and independently. CIONIC is now licensed to ship to over 90% of US states (and growing), with over 400 prescribing institutions and 200,000 hours of customer use. #neurotech #multiples...
Chronic Kidney Disease and the It Takes Two™ Initiative
December 14, 2023 06:28 - 9 minutes - 9.02 MBDr. Charles Vega, MD, Family Medicine Specialist and Director of Irvine’s Program in Medical Education for the Latino Community discusses Boehringer Ingelheim and Lilly’s launch of It Takes 2, a new health initiative to elevate the importance of complete testing and early diagnosis of kidney disease, particularly among those who have type 2 diabetes or high blood pressure and are at greater risk for it. Boehringer Ingelheim and Lilly partnered with musical artist Rob Base to release a remix ...
Can Artificial Intelligence be used to Diagnose Glaucoma?
December 14, 2023 06:27 - 8 minutes - 8.14 MBDr. Michael Boland, MD, PhD, Site Director, Mass Eye and Ear, Lexington, Medical Director, Practice Innovation for Ophthalmology, Massachusetts Eye and Ear and Associate Professor of Ophthalmology, Harvard Medical School discusses presentations from the 2023 American Academy of Ophthalmology annual meeting regarding AI and glaucoma. #AAO2023 #AI #glaucoma Dr. Boland is a member of the Glaucoma Service at Mass Eye and Ear and the Site Director at Mass Eye and Ear, Lexington. He has complete...
Rheumatoid Arthritis and the Potential of Exploring Combination Therapies
December 14, 2023 06:26 - 9 minutes - 8.5 MBDr. Terence Rooney, Vice President, Rheumatology, Immunology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development shares new data that was presented from the Phase 2a IRIS proof-of-concept study, demonstrating the efficacy and safety of nipocalimab in the first-ever clinical study of an FcRn inhibitor in adults living with moderate to severe rheumatoid arthritis, and supporting its progression into an anti-TNF combination study. These data were presented ...
European Society for Medical Oncology (ESMO) 2023 - Abstracts #2362MO and #2359O
December 06, 2023 12:18 - 9 minutes - 8.42 MBDr. Arlene Siefker-Radtke, Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center in Houston, TX discusses her presentation at ESMO 2023, abstracts #2362MO and #2359O on Erdafitinib (erda) from the Phase 3 THOR study. For more information visit: https://www.annalsofoncology.org/article/S0923-7534(23)04015-2/fulltext and https://www.nejm.org/doi/full/10.1056/NEJMoa2308849 #ESMO2023 Arlene O Siefker-Radtke, MD...
European Society for Medical Oncology (ESMO) 2023 - Presidential Symposium / Abstract #LBA5
December 06, 2023 12:17 - 7 minutes - 7.12 MBDr. Nicolas Girard, Professor of Respiratory Medicine at Versailles Saint Quentin University and head of the Curie-Montsouris Thorax Institute discusses his presentation at ESMO 2023 - Presidential Symposium / Abstract #LBA5 - Amivantamab plus carboplatin/pemetrexed vs carboplatin/pemetrexed as first line treatment in EGFR exon 20 insertion-mutated advanced non-small cell lung cancer (NSCLC): primary results from PAPILLON, a randomized phase 3 global study. #ESMO2023 #LBA5 Nicolas Girard i...
European Society for Medical Oncology (ESMO) 2023 - Mini Oral/Abstract #LBA85
December 06, 2023 12:12 - 8 minutes - 8.14 MBDr. Kim Chi, Senior Research Scientist, Vancouver Prostate Centre discusses his presentation at ESMO 2023, abstract #LBA85 - Niraparib (NIRA) with abiraterone acetate plus prednisone (AAP) as first-line (1L) therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations: Three-year update and final analysis (FA) of MAGNITUDE. #ESMO2023 Senior Research Scientist, Vancouver Prostate Centre Chief Medical Offic...
Spectral AI - Advancing AI-driven Burn Wound Imaging Technology
December 06, 2023 12:11 - 10 minutes - 13.9 MBWensheng Fan, CEO and co-founder of Spectral AI, a company that is using artificial intelligence to revolutionize diagnostics and wound care, discusses the recently awarded Biomedical Advanced Research and Development Authority (BARDA) Project BioShield Contract. This contract is for the advanced development of the DeepView System, the Company’s AI-driven burn wound imaging technology, to be used at emergency departments, trauma centers and burn centers, for both routine burn care and as a ...
Voyce™ - On-Demand Medical Interpretation
December 06, 2023 12:09 - 11 minutes - 15.3 MBVoyce is a technology-driven company dedicated to breaking down language barriers in healthcare. CEO of Voyce, Andrew Royce, discusses how the company delivers simple, seamless, and secure on-demand medical interpretation in more than 240 languages and dialects, 24/7. The app is designed to work with smartphones, tablets, laptops, desktops, iOS, Android, Telephonic and APIs. It is easily integrated into virtual care platforms and EMRs, such as EPIC, Teladoc, and Zoom. #languageinterpreation...
Global Phase 3 innovaTV301 Trial Results
November 29, 2023 13:32 - 7 minutes - 10.6 MBTrial investigator Brian Slomovitz, MD, Director of Gynecologic Oncology and Co-Chair of the Cancer Research Committee at Mount Sinai Medical Center, discusses results from the global, randomized, open-label Phase 3 innovaTV 301 trial, which showed treatment with tisotumab vedotin demonstrated statistically significant and clinically meaningful overall survival, progression-free survival, and objective response in recurrent or metastatic cervical cancer patients with disease progression on o...
Comera Life Sciences on Developing a New Generation of Biologic Medicines
November 29, 2023 13:31 - 9 minutes - 13 MBJeff Hackman, CEO of Comera Life Sciences, discusses how the company uses its proprietary SQore™ viscosity reduction platform to transform intravenous (IV) biologics into subcutaneous (SQ) versions that patients can self-administer in a single dose. High viscosity is a significant hurdle to formulating subcutaneous biologics and Comera’s addition of excipients, such as caffeine, interrupts intermolecular interactions to reduce viscosity of high concentration monoclonal antibody formulations....
Medtronic Receives CE Mark for Evolut™ FX TAVI System
November 29, 2023 13:30 - 10 minutes - 9.27 MBDr. Jeffrey Popma, MD, Vice President and Chief Medical Officer for Coronary, Renal Denervation, and Structural Heart at Medtronic discusses Medtronic’s recent CE Mark approval for the Evolut™ FX TAVI System and the increased need for solutions for patients with symptomatic severe aortic stenosis. #Medtronics #Hearthealth Jeffrey Popma, MD, is the Vice President and Chief Medical Officer for Coronary, Renal Denervation, and Structural Heart at Medtronic, a position that he has held since...
Somatus - Revolutionizing Kidney Care
November 29, 2023 13:29 - 11 minutes - 10.7 MBDr. Joe Kimura, Chief Medical Officer, discusses how Somatus deployed a robust transitions-of-care (TOC) service to help their patients safely transition from acute inpatient care to home. Somatus provides TOC services to CKD3/4/5 and ESKD patients and has found patients in the program are 49% less likely to be re-admitted to the hospital compared to usual care. #Health #Healthcare #Kidneycare Dr. Kimura joins Somatus from Atrius Health, a 650+ physician Boston-based independent multisp...
Dr. Thomas Carroll Shares Exciting Updates in ENT Following the 2023 American Academy of Head and Neck Surgery Conference
November 29, 2023 13:28 - 9 minutes - 8.62 MBDr. Thomas Carroll, Director at Brigham and Women's Voice Program and the Medical Director of Otolaryngology Clinics at Brigham and Women's Hospital discusses his presentations from the 2023 American Academy of Head and Neck Surgery conference, hot topics, and current challenges in the field of ENT. #AAOHNS #Brigham&Womens Dr. Thomas Carroll is the Director at Brigham and Women's Voice Program and the Medical Director of Otolaryngology Clinics at Brigham and Women's Hospital. He is the Pre...
Survey Results Spotlight Advanced Practice Providers (APPs)
November 29, 2023 13:27 - 9 minutes - 13.3 MBWendy Vogel, executive director of the Advanced Practitioner Society for Hematology and Oncology (APSHO) discusses the Make It HAPPen™ campaign and the recent survey that validated the impact APPs have on multiple myeloma patient journeys as well as the need to provide APPs with further educational resources. #MakeItHappen #APPs #APSHO Wendy H. Vogel, MSN, FNP, AOCNP ®, Harborside Executive Director Wendy H. Vogel, MSN, FNP, AOCNP ®, is an oncology nurse practitioner from Kingsport, Tenn...
Hot Topics Following the 2023 American Academy of Head and Neck Surgery Conference
November 29, 2023 13:26 - 8 minutes - 8.2 MBDr. Dan Faden, Specialist and Investigator in Head and Neck Surgery at Massachusetts General Brigham Mass Eye & Ear discusses his presentations from the 2023 American Academy of Head and Neck Surgery conference titled Ten Hot Topics in Head and Neck Surgical Oncology Panel and Great Debates: ctDNA: Is It Ready for Prime Time? #AAOHNS #HeadAndNeckSurgery #MassGeneralBrigham Dr. Dan Faden is a specialist, investigator, and surgeon, for the Mike Toth Head and Neck Cancer Research Center at Ma...
Atrial Fibrillation (AFib) Awareness
November 21, 2023 10:07 - 9 minutes - 8.73 MBDr. Khaldoun Tarakji, Vice President and Chief Medical Officer of the Cardiac Ablation Solutions (CAS) Operating Unit (OU) at Medtronic discusses signs and symptoms of AFib and the latest innovations and advancements related to AFib. #AtrialFibrillationAwareness Tarakji, MD, MPH, is the chief medical officer (CMO) of the Cardiac AblationDr. Khaldoun Tarakji, Vice President and Chief Medical OfficerKhaldoun Solutions (CAS) Operating Unit (OU) at Medtronic. In this role, Dr. Tarakji is h...
Invivyd, Inc - Development of a Monoclonal Antibody for COVID-19 Prevention in Vulnerable Populations
November 21, 2023 10:05 - 9 minutes - 12.5 MBDave Hering, CEO of Invivyd, Inc, a biopharmaceutical company discusses the development of a monoclonal antibody to prevent COVID-19 in immunocompromised people, through their pivotal Phase 3 trial called CANOPY. This is the final step in a rapid development program for an antibody infusion to prevent symptomatic COVID-19 in vulnerable populations. #mAb #COVID19 #immunocompromised Dave Hering, M.B.A. has served as our Chief Executive Officer and a member of the Board of Directors sinc...
Eye Corps - Working to End Preventable Blindness in Rural Sub-Saharan Africa
November 21, 2023 10:04 - 9 minutes - 8.71 MBDr. Susan MacDonald, MD, board-certified ophthalmologist, Co-founder and CEO of Eye Corps discusses Eye Corps' mission to eliminate preventable blindness in sub-Saharan Africa through strategic partnerships with the local medical community and ophthalmic training institutions. Eye Corps works to build a sustainable infrastructure for eye care delivery in sub-Saharan Africa with a focus on eliminating gender inequity in vision care. #TogetherInSight #humanitarian #eyecare Susan MacDonald, ...
GE HealthCare - Reimagining Better Health
November 21, 2023 10:03 - 9 minutes - 12.5 MBAndy DeLaO, Chief Strategy & Marketing Officer at GE HealthCare U.S. and Canada, discusses findings from "Reimagining Better Health," GE HealthCare's first-ever international study on the state of healthcare. The study amplifies the united perspectives of patients and clinicians who envision a more human and flexible healthcare experience. #ReimaginingBetterHealth #GEHealthCare #futureofhealthcare Andy DeLaO is the Chief Strategy & Marketing Officer for GE Healthcare’s business focused o...
Schizophrenia Awareness and New Long-Acting Treatment
November 21, 2023 10:02 - 10 minutes - 9.9 MBDr. Christoph Correll, Professor of Psychiatry at the Zucker School of Medicine discusses common misconceptions about schizophrenia and the challenges that people experience when managing this condition, including adherence to medication and the risk of relapse. Dr. Correll also discusses a recently-approved treatment for adults with schizophrenia called UZEDY™ (risperidone) extended-release injectable suspension, and new data that build on our existing knowledge about this treatment option....
A New Breakthrough in Early Detection of Alzheimer's Disease Risk
November 13, 2023 13:38 - 8 minutes - 8.18 MBDr. Michael Racke, a board-certified neurologist and medical director of neurology at Quest Diagnostics, discusses the advances in blood and other tests for Alzheimer's Disease. He’ll also talk about other practical ways to talk to healthcare providers about the disease, new research that shows how lifestyle changes may reduce risk, and questions people should ask their doctor to assess their own risk. For more information visit questforthecure.com #QuestDiagnostics Dr. Michael K. Racke is...
AstraZeneca - Trial Data for Gastric and Gastroesophageal Junction Cancers
November 13, 2023 13:37 - 7 minutes - 10.8 MBShubh Goel, VP, Head of Immunoncology and GI Tumors Franchise at AstraZeneca discusses data presented at the European Society for Medical Oncology (ESMO) 2023 from the MATTERHORN Phase 3 trial data where patients with gastric and gastroesophageal junction cancers are treated with IMFINZI ® (durvalumab) + chemotherapy. The data discusses the improvement seen in patients who were treated with this combination therapy versus receiving the current standard of care, which is just chemo. This trea...
Marker Therapeutics - Next-Generation T-Cell-Based Immunotherapies
November 13, 2023 13:36 - 9 minutes - 8.84 MBDr. Juan Vera, CEO of Marker Therapeutics, a clinical-stage immuno-oncology company focused on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications discusses the APOLLO trial that is investigating MT-601, a multi-tumor-associated antigen (multiTAA)-specific T cell product targeting six antigens, for the treatment of patients with lymphoma who have failed or are ineligible to receive anti-CD19 CAR T cell treatment....
Teva - Real World Data on AUSTEDO ®
November 13, 2023 13:35 - 8 minutes - 8.05 MBReturning guest, Dr. Andrew Cutler, Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University and CEO of Florida Clinical Research Center, LLC discusses real-world data from the START study demonstrating favorable efficacy and adherence among people living with TD who used a 4-week titration kit to reach optimal dosing with AUSTEDO ® (deutetrabenazine). Andrew J. Cutler, MD Clinical Associate Professor of Psychiatry SUNY Upstate Medical University Syracuse, New York CE...
Ordaōs AI-driven drug design and mini-proteins
November 13, 2023 13:34 - 9 minutes - 13.1 MBDavid Longo, Co-Founder and CEO of Ordaōs, an AI-driven drug design company, discusses generative AI and how Ordaos is using AI to design novel and customized mini-proteins they refer to as miniPRO ™. They achieve this development through their Odaōs Design Engine which leverages continuous learning loops and proprietary data sets to translate human-defined product criteria into machine-designed mini-proteins which can be safer and more effective. David will discuss what HCPs need to know ab...
Aetion Inc. - Women-Led Health Tech Company Driving Real-World Results Forward
November 13, 2023 13:33 - 8 minutes - 8.24 MBAetion Chief Science Officer, Nicolle Gatto, Ph.D., M.P.H., shares how the organization leverages real-world evidence (RWE) to support research and development activities as well as regulatory decisions to inform healthcare’s most critical decisions, advance access to medications, and ultimately improve patient care. #Aetion Nicolle Gatto, Ph.D., M.P.H. Chief Science Officer Nicolle is an epidemiologist with 20 years of industry experience. She serves as a senior scientific voice ensurin...
Anxiety - A Natural Human Experience
October 29, 2023 11:31 - 9 minutes - 8.39 MBDr. David Rosmarin, Ph.D, is the Director of the Spirituality and Mental Health Program at McLean Hospital, associate professor of psychology in the Department of Psychiatry at Harvard Medical School, and founder of Center for Anxiety discusses his new book (Oct 2023) titled "Thriving With Anxiety." He reframes anxiety and explains Anxiety is not a disease; it is a natural human experience that can help us thrive throughout life when we learn to harness it as a resource. For further informa...
Ambee - Climate Change and the Environment
October 29, 2023 11:30 - 8 minutes - 11.4 MBJaideep Singh, Co-Founder and CEO of Ambee talks about his passion for the environment, helping people improve their lives, and the groundbreaking environmental data the company has uncovered and how they’re making it actionable with a tech service like Allegra Airways. #Ambee Jaideep Singh is CEO and co-founder at Ambee, a climate tech startup that provides businesses with accurate spatio-temporal insights on climate factors – pollen, emissions, air quality, wildfires – across the world. ...
First-of-its-Kind Allergy & Air Quality Map App
October 29, 2023 11:29 - 8 minutes - 8.03 MBDr. Purvi Parikh, a renowned allergist at NYU Langone Health discusses the launch of Allegra's new, first-of-its-kind map app called Airways that guides users to their destinations with real-time cleaner routes (least amount of air pollution and pollen). It essentially identifies a cleaner air commuting route and the best routes to avoid, like the Waze traffic app, but for clean-route commuting. #AllegraAirways Dr. Purvi Parik: Dr. Purvi Parikh is an adult and pediatric allergist and immun...
Maternal Mortality and Improving Quality of Care
October 29, 2023 11:28 - 11 minutes - 15.8 MBLora Sparkman, RN, BSN, MHA, VP, Partner, Clinical Solutions, Patient Safety and Quality at Relias and Nurse.com ambassador, discusses the current maternal mortality crisis and steps healthcare organizations can take to improve the quality of care. #MaternalHealth #MaternalMortality #MaternalMentalHealth Lora Sparkman, MHA, BSN, RN, VP, Partner, Clinical Solutions, Patient Safety and Quality at Relias, has been a nurse for 37 years, with 10 at the bedside and 27 in health administration. S...
Colorectal Cancer Survivor Story
October 29, 2023 11:27 - 12 minutes - 16.5 MBMeredith Huetter, a stage lll colorectal cancer survivor, shares her personal story of learning she had CRC and how her treatment journey has gone thus far. #ColorectalCander In March 2020, I started having GI issues, including a change in my bowel habits and blood in my stool. I immediately attributed the issues to stress related to the recent start of the pandemic. I met with my general practitioner a couple of months later as I had continued issues, including narrower stools than usual...
Babson Diagnostics™ - BetterWay™ Blood Testing
October 29, 2023 11:26 - 8 minutes - 8.11 MBDr. David Stein, PhD, CEO and Director of Babson Diagnostics discusses how Babson is reimagining the blood testing process by only using only a pea-sized amount of blood collected from the finger. Babson’s BetterWay™ Blood Testing eco-system is unique because it brings medically accurate blood testing to the convenience of a retail pharmacy, empowering people to better take charge of their health. #BloodTesting #BetterWay #Diagnostics Dr. David Stein, Ph.D., Chief Executive Officer and ...
Seasonal Affective Disorder (SAD)
October 24, 2023 03:09 - 9 minutes - 8.72 MBNorman E. Rosenthal is a psychiatrist and scientist who first described SAD in 1984 and pioneered light therapy as a treatment. Dr. Rosenthal is currently Clinical Professor of Psychiatry at Georgetown University School of Medicine and the author of several books, his most recent being Defeating SAD (Seasonal Affective Disorder): A Guide to Health and Happiness Through All Seasons #SeasonalAffectiveDisorder Norman E. Rosenthal is a world-renowned psychiatrist, public speaker, and best-sell...
Flu Vaccine Options for Older Adults and Those with Chronic Health Conditions
October 24, 2023 03:08 - 9 minutes - 13.1 MBChad Worz, PharmD, BCGP, FASCP, Executive Director and Chief Executive Officer of the American Society of Consultant Pharmacists (ASCP) discusses a new flu vaccination campaign from the ASCP and Sanofi that encourages older adults and those with chronic conditions to speak with their healthcare providers or pharmacists about flu vaccine options that may be right for them. #FluVaccine Chad Worz, PharmD, BCGP, is the Chief Executive of ASCP. A board-certified geriatric pharmacist and graduat...
Atossa Therapeutics - Developing Innovative Therapies To Address Unmet Needs In Breast Cancer
October 24, 2023 03:07 - 8 minutes - 8.3 MBDr. Steven Quay, Chairman of the Board and CEO of Atossa Therapeutics, a company focused on preventing breast cancer in at-risk women and treating breast cancer in women of all ages, discusses the development of a drug called (z)-endoxifen for breast cancer treatment which is currently undergoing 3 separate phase 2 clinical trials in the US. #BreastCancer #Oncology #ClinicalTrials Steven Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharm...
CymaBay - Positive Topline Results from Pivotal Ph. 3 Trial in PBC
October 24, 2023 03:06 - 10 minutes - 9.69 MBSujal Shah, President and CEO of CymaBay Therapeutics, a clinical-stage biopharmaceutical company, discusses the positive topline results from its Phase 3 pivotal RESPONSE study of seladelpar in patients with primary biliary cholangitis (PBC), a rare, chronic inflammatory liver disease. This is the first potential therapy to show promise in significantly improving markers associated with risk of disease progression and significantly reducing itch. #CymaBay Sujal Shah – President and Chief ...
Southern California Hospice Nonprofit Provides Dignified Solution to Hidden Housing Crisis
October 24, 2023 03:05 - 9 minutes - 12.5 MBMichelle Wulfestieg, Executive Director at Southern California Hospice Foundation and CEO of Heavenly Home discusses how she is fighting the battle of homelessness for the terminally ill and how she is accepting those at Heavenly Home who may lack financial resources and have no other options for end-of-life care. # SCHF #SoCALHospice #socalhospicefoundation With the heart of a servant-leader, Michelle Wulfestieg is a two-time stroke survivor who understands just how precious life is and...
AstraZeneca's combo treatment cuts NSCLC progression by 38% in FLAURA2 Phase III Trial
October 17, 2023 11:06 - 7 minutes - 10.8 MBArun Krishna, VP, Head of Lung Cancer Franchise, US Oncology Business Unit at AstraZeneca discusses the positive results from the FLAURA2 Phase III trial of TAGRISSO ® (osimertinib) plus chemotherapy and its significance as a new potential treatment option for patients with advanced lung cancer. #LungCancer Arun Krishna, Vice President, Head of Lung Cancer Franchise, US Oncology Business Unit, is responsible for overseeing all lung cancer US sales and the commercialization of TAGRISSO and ...
New Findings Reveal Why 45-Year-Olds Would Avoid or Delay Colorectal Cancer Screenings
October 17, 2023 11:04 - 8 minutes - 7.89 MBReturning guest, Dr. Paul Limburg, Chief Medical Officer, Screening at Exact Sciences discusses recent research that revealed countless reasons why 45-year-olds in the U.S. aren’t getting screened for this deadly condition despite recommendations by national screening guidelines. He talks more about how screening can change the course of this deadly disease. #ExactSciences Paul Limburg has served as our Chief Medical Officer, Screening since 2018. Dr. Limburg holds the academic rank of Pro...
iSpecimen - Online Marketplace for Human Biospecimens
October 17, 2023 11:03 - 9 minutes - 13.4 MBTracy Curley, the CEO of iSpecimen, an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, discusses the iSpecimen platform, the importance of just-in-time biobanking and what’s up next for the industry. Tracy is an experienced, results-oriented business builder focused on leading iSpecimen’s vision for progressive financial performance, expansion and growth in today’s dynamic healthcare and biotech...
Final Dataset of Phase 2 ENTRIGUE Trial of Pegozafermin
October 17, 2023 11:02 - 10 minutes - 9.27 MBDr. Deepak Bhatt, MD, MPH, Director of Mount Sinai Heart and Principal Study Author discusses the final dataset from the Phase 2 ENTRIGUE trial of 89bio’s pegozafermin in patients with severe hypertriglyceridemia (SHTG) that was published online in "Nature Medicine" (June 24, 2023). To learn more about pegozafermin’s indications in non-alcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG), please visit https://www.89bio.com/pipeline/. #SHTG #89bio #NatureMedicine Deepak L...
American Heart Association - Nation of Lifesavers™ Initiative
October 17, 2023 11:01 - 10 minutes - 9.69 MBDr. Comilla Sasson, MD, PhD, Vice President for Healthcare Business Solutions at the American Heart Association and a practicing Emergency Medicine physician in Denver, Colorado discusses AHA’s newly launched Nation of Lifesavers™ initiative to double survival rates from sudden cardiac arrest by 2030. The new multi-year initiative will ensure teens and adults can learn about CPR and AED use, share that knowledge with friends and family and engage employers, policymakers, philanthropists, and...
Ovarian Cancer - The Importance of Genetic Testing
October 11, 2023 12:42 - 5 minutes - 5 MBDr. Erin Crane, MD, MPH, gynecologic oncologist with the Atrium Health Levine Cancer Institute and Bobbie, an ovarian cancer patient discuss the prevalence of ovarian cancer, risk factors, the importance of biomarker testing, the diagnosis journey, and important questions to ask after diagnosis. #OvarianCancer Erin K. Crane, MD, MPH, is a gynecologic oncologist with the Atrium Health Levine Cancer Institute in Charlotte, North Carolina. A graduate of the SUNY Upstate Medical University in...